Citations (50)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Rubika Balendra, Ashley R. Jones, Ahmad Al Khleifat, Theresa Chiwera, Paul Wicks, Carolyn A. Young, Pamela J. Shaw, Martin R. Turner, P. Nigel Leigh & Ammar Al-Chalabi. (2023) Comparison Of King’s Clinical Staging In Multinational Amyotrophic Lateral Sclerosis Cohorts. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 24:1-2, pages 71-81.
Read now
Read now
Paul Mehta, Jaime Raymond, Reshma Punjani, Moon Han, Theodore Larson, Wendy Kaye, Lorene M. Nelson, Barbara Topol, Oleg Muravov, Corina Genson & D. Kevin Horton. (2023) Prevalence of amyotrophic lateral sclerosis in the United States using established and novel methodologies, 2017. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 24:1-2, pages 108-116.
Read now
Read now
Pamela A. McCombe, Fleur C Garton, Matthew Katz, Naomi R Wray & Robert D Henderson. (2020) What do we know about the variability in survival of patients with amyotrophic lateral sclerosis?. Expert Review of Neurotherapeutics 20:9, pages 921-941.
Read now
Read now
. (2018) Theme 1 Genetics and genomics. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 19:sup1, pages 91-111.
Read now
Read now
Arens Taga & Nicholas J. Maragakis. (2018) Current and emerging ALS biomarkers: utility and potential in clinical trials. Expert Review of Neurotherapeutics 18:11, pages 871-886.
Read now
Read now
Samad Jahandideh, Albert A. Taylor, Danielle Beaulieu, Mike Keymer, Lisa Meng, Amy Bian, Nazem Atassi, Jinsy Andrews & David L. Ennist. (2018) Longitudinal modeling to predict vital capacity in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 19:3-4, pages 294-302.
Read now
Read now
Malcolm Proudfoot, Ashley Jones, Kevin Talbot, Ammar Al-Chalabi & Martin R. Turner. (2016) The ALSFRS as an outcome measure in therapeutic trials and its relationship to symptom onset. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 17:5-6, pages 414-425.
Read now
Read now
Muzammil Arif Din Abdul Jabbar, Ling Guo, Sonakshi Nag, Yang Guo, Zachary Simmons, Erik P. Pioro, Savitha Ramasamy & Crystal Jing Jing Yeo. Predicting amyotrophic lateral sclerosis (ALS) progression with machine learning. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 0:0, pages 1-14.
Read now
Read now
Articles from other publishers (42)
Erica Tavazzi, Enrico Longato, Martina Vettoretti, Helena Aidos, Isotta Trescato, Chiara Roversi, Andreia S. Martins, Eduardo N. Castanho, Ruben Branco, Diogo F. Soares, Alessandro Guazzo, Giovanni Birolo, Daniele Pala, Pietro Bosoni, Adriano Chiò, Umberto Manera, Mamede de Carvalho, Bruno Miranda, Marta Gromicho, Inês Alves, Riccardo Bellazzi, Arianna Dagliati, Piero Fariselli, Sara C. Madeira & Barbara Di Camillo. (2023) Artificial intelligence and statistical methods for stratification and prediction of progression in amyotrophic lateral sclerosis: A systematic review. Artificial Intelligence in Medicine 142, pages 102588.
Crossref
Crossref
Erica Tavazzi, Roberto Gatta, Mauro Vallati, Stefano Cotti Piccinelli, Massimiliano Filosto, Alessandro Padovani, Maurizio Castellano & Barbara Di Camillo. (2023) Leveraging process mining for modeling progression trajectories in amyotrophic lateral sclerosis. BMC Medical Informatics and Decision Making 22:S6.
Crossref
Crossref
Meysam Ahangaran, Abdolrahman Peimankar, Uffe Kock Wiil & Adriano Chio. (2022) Impact of laboratory biomarkers on ALS disease progression: a probabilistic causation approach. Network Modeling Analysis in Health Informatics and Bioinformatics 11:1.
Crossref
Crossref
Yuko Kobayakawa, Koji Todaka, Yu Hashimoto, Senri Ko, Wataru Shiraishi, Junji Kishimoto, Jun-ichi Kira, Ryo Yamasaki & Noriko Isobe. (2022) A novel quantitative indicator for disease progression rate in amyotrophic lateral sclerosis. Journal of the Neurological Sciences 442, pages 120389.
Crossref
Crossref
Divya Ramamoorthy, Kristen Severson, Soumya Ghosh, Karen Sachs, Emily G. Baxi, Alyssa N. Coyne, Elizabeth Mosmiller, Lindsey Hayes, Aianna Cerezo, Omar Ahmad, Promit Roy, Steven Zeiler, John W. Krakauer, Jonathan Li, Aneesh Donde, Nhan Huynh, Miriam Adam, Brook T. Wassie, Alex Lenail, Natasha Leanna Patel-Murray, Yogindra Raghav, Karen Sachs, Velina Kozareva, Stanislav Tsitkov, Tobias Ehrenberger, Julia A. Kaye, Leandro Lima, Stacia Wyman, Edward Vertudes, Naufa Amirani, Krishna Raja, Reuben Thomas, Ryan G. Lim, Ricardo Miramontes, Jie Wu, Vineet Vaibhav, Andrea Matlock, Vidya Venkatraman, Ronald Holewenski, Niveda Sundararaman, Rakhi Pandey, Danica-Mae Manalo, Aaron Frank, Loren Ornelas, Lindsey Panther, Emilda Gomez, Erick Galvez, Daniel Perez, Imara Meepe, Susan Lei, Louis Pinedo, Chunyan Liu, Ruby Moran, Dhruv Sareen, Barry Landin, Carla Agurto, Guillermo Cecchi, Raquel Norel, Sara Thrower, Sarah Luppino, Alanna Farrar, Lindsay Pothier, Hong Yu, Ervin Sinani, Prasha Vigneswaran, Alexander V. Sherman, S. Michelle Farr, Berhan Mandefro, Hannah Trost, Maria G. Banuelos, Veronica Garcia, Michael Workman, Richie Ho, Robert Baloh, Jennifer Roggenbuck, Matthew B. Harms, Carolyn Prina, Sarah Heintzman, Stephen Kolb, Jennifer Stocksdale, Keona Wang, Todd Morgan, Daragh Heitzman, Arish Jamil, Jennifer Jockel-Balsarotti, Elizabeth Karanja, Jesse Markway, Molly McCallum, Tim Miller, Ben Joslin, Deniz Alibazoglu, Senda Ajroud-Driss, Jay C. Beavers, Mary Bellard, Elizabeth Bruce, Nicholas Maragakis, Merit E. Cudkowicz, James Berry, Terri Thompson, Steven Finkbeiner, Leslie M. Thompson, Jennifer E. Van Eyk, Clive N. Svendsen, Jeffrey D. Rothstein, Jonathan D. Glass, Christina N. Fournier, Alexander Sherman, Christian Lunetta, David Walk, Ghazala Hayat, James Wymer, Kelly Gwathmey, Nicholas Olney, Senda Ajroud-Driss, Terry Heiman-Patterson, Ximena Arcila-Londono, Kenneth Faulconer, Ervin Sanani, Alex Berger, Julia Mirochnick, Todd M. Herrington, James D. Berry, Kenney Ng & Ernest Fraenkel. (2022) Identifying patterns in amyotrophic lateral sclerosis progression from sparse longitudinal data. Nature Computational Science 2:9, pages 605-616.
Crossref
Crossref
Erica Tavazzi, Sebastian Daberdaku, Alessandro Zandonà, Rosario Vasta, Beatrice Nefussy, Christian Lunetta, Gabriele Mora, Jessica Mandrioli, Enrico Grisan, Claudia Tarlarini, Andrea Calvo, Cristina Moglia, Vivian Drory, Marc Gotkine, Adriano Chiò, Barbara Di Camillo, A. Chiò, Rita Levi Montalcini, A. Calvo, C. Moglia, A. Canosa, U. Manera, R. Vasta, F. Palumbo, A. Bombaci, M. Grassano, M. Brunetti, F. Casale, G. Fuda, P. Salomone, B. Iazzolino, L. Peotta, P. Cugnasco, G. De Marco, M. C. Torrieri, S. Gallone, M. Barberis, L. Sbaiz, S. Gentile, A. Mauro, L. Mazzini, F. Marchi, L. Corrado, S. D’Alfonso, A. Bertolotto, M. Gionco, D. Leotta, E. Oddenino, R. Cavallo, M. De Mattei, G. Gusmaroli, C. Comi, C. Labate, F. Poglio, L. Ruiz, D. Ferrandi, L. Testa, E. Rota, M. Aguggia, N. Di Vito, P. Meineri, P. Ghiglione, N. Launaro, M. Dotta, A. Sapio, M. Giovanni, J. Mandrioli, J. Mandrioli, N. Fini, I. Martinelli, E. Zucchi, G. Gianferrari, C. Simonini, M. Vinceti, S. Meletti, V. Vacchiano, R. Liguori, Fabrizio Salvi, Ilaria Bartolomei, Roberto Michelucci, P. Cortelli, A. M. Borghi, A. Zini, R. Rinaldi, P. Cortelli, E. Sette, V. Tugnoli, M. Pugliatti, E. Canali, L. Codeluppi, F. Valzania, L. Zinno, G. Pavesi, D. Medici, G. Pilurzi, E. Terlizzi, D. Guidetti, S. Pasqua, M. Santangelo, M. Bracaglia, P. DeMassis, M. Casmiro, P. Querzani, S. Morresi, M. Longoni, A. Patuelli, S. Malagù, M. Longoni, M. Currò Dossi & S. Vidale. (2022) Predicting functional impairment trajectories in amyotrophic lateral sclerosis: a probabilistic, multifactorial model of disease progression. Journal of Neurology 269:7, pages 3858-3878.
Crossref
Crossref
Afaf Shaabi. (2022) Modeling Amyotrophic Lateral Sclerosis Progression: Logic in the Logit. Cureus.
Crossref
Crossref
Paolo Tornese, Stefania Lalli, Antoniangela Cocco & Alberto Albanese. (2022) Review of disease-modifying drug trials in amyotrophic lateral sclerosis. Journal of Neurology, Neurosurgery & Psychiatry 93:5, pages 521-529.
Crossref
Crossref
Vivek P. Chavda, Chirag Patel, Dharti Modh, Yavuz Nuri Ertas, Shreya S. Sonak, Nafesa K. Munshi, Krishnan Anand, Arun Soni & Sonal Pande. (2022) Therapeutic Approaches to Amyotrophic Lateral Sclerosis from the Lab to the Clinic. Current Drug Metabolism 23:3, pages 200-222.
Crossref
Crossref
Ernesto Iadanza, Rachele Fabbri, Francesco Goretti, Giovanni Nardo, Elena Niccolai, Caterina Bendotti & Amedeo Amedei. (2022) Machine learning for analysis of gene expression data in fast- and slow-progressing amyotrophic lateral sclerosis murine models. Biocybernetics and Biomedical Engineering 42:1, pages 273-284.
Crossref
Crossref
Kenney Ng, Mohamed Ghalwash, Prithwish Chakraborty, Daby M. Sow, Akira Koseki, Hiroki Yanagisawa & Michiharu Kudo. 2022. Healthcare Information Management Systems. Healthcare Information Management Systems
247
276
.
Simon Witzel, Felix Frauhammer, Petra Steinacker, David Devos, Pierre-François Pradat, Vincent Meininger, Steffen Halbgebauer, Patrick Oeckl, Joachim Schuster, Simon Anders, Johannes Dorst, Markus Otto & Albert C. Ludolph. (2021) Neurofilament light and heterogeneity of disease progression in amyotrophic lateral sclerosis: development and validation of a prediction model to improve interventional trials. Translational Neurodegeneration 10:1.
Crossref
Crossref
Tsun-Haw Toh, Nur Adilah Abdul-Aziz, Mohd Azly Yahya, Khean-Jin Goh, Ee-Chin Loh, David Paul Capelle & Nortina Shahrizaila. (2021) A model incorporating ultrasound to predict the probability of fast disease progression in amyotrophic lateral sclerosis. Clinical Neurophysiology 132:10, pages 2722-2728.
Crossref
Crossref
Danielle Beaulieu, Albert A. Taylor, Dustin Pierce, Jonavelle Cuerdo, Mark Schactman, Mike Keymer & David L. Ennist. 2021. Neurotherapeutics in the Era of Translational Medicine. Neurotherapeutics in the Era of Translational Medicine
333
366
.
Ben Hadad & Boaz Lerner. (2020) Domain adaptation from clinical trials data to the tertiary care clinic – Application to ALS. Domain adaptation from clinical trials data to the tertiary care clinic – Application to ALS.
Ying Si, Mohamed Kazamel, Yuri Kwon, Ikjae Lee, Tina Anderson, Siyu Zhou, Marcas Bamman, Derek Wiggins, Thaddaeus Kwan & Peter H. King. (2020) The vitamin D activator CYP27B1 is upregulated in muscle fibers in denervating disease and can track progression in amyotrophic lateral sclerosis. The Journal of Steroid Biochemistry and Molecular Biology 200, pages 105650.
Crossref
Crossref
Dan Halbersberg & Boaz Lerner. (2019) Temporal Modeling of Deterioration Patterns and Clustering for Disease Prediction of ALS Patients. Temporal Modeling of Deterioration Patterns and Clustering for Disease Prediction of ALS Patients.
Jonathan Gordon & Boaz Lerner. (2019) Insights into Amyotrophic Lateral Sclerosis from a Machine Learning Perspective. Journal of Clinical Medicine 8:10, pages 1578.
Crossref
Crossref
Ming Tang, Chao Gao, Stephen A. Goutman, Alexandr Kalinin, Bhramar Mukherjee, Yuanfang Guan & Ivo D. Dinov. (2018) Model-Based and Model-Free Techniques for Amyotrophic Lateral Sclerosis Diagnostic Prediction and Patient Clustering. Neuroinformatics 17:3, pages 407-421.
Crossref
Crossref
Nick S. Verber, Stephanie R. Shepheard, Matilde Sassani, Harry E. McDonough, Sophie A. Moore, James J. P. Alix, Iain D. Wilkinson, Tom M. Jenkins & Pamela J. Shaw. (2019) Biomarkers in Motor Neuron Disease: A State of the Art Review. Frontiers in Neurology 10.
Crossref
Crossref
B. Gille, M. De Schaepdryver, J. Goossens, L. Dedeene, J. De Vocht, E. Oldoni, A. Goris, L. Van Den Bosch, B. Depreitere, K. G. Claeys, J. Tournoy, P. Van Damme & K. Poesen. (2018) Serum neurofilament light chain levels as a marker of upper motor neuron degeneration in patients with Amyotrophic Lateral Sclerosis. Neuropathology and Applied Neurobiology 45:3, pages 291-304.
Crossref
Crossref
Rebekah M. Ahmed, Katherine Phan, Elizabeth Highton‐Williamson, Cherie Strikwerda‐Brown, Jashelle Caga, Eleanor Ramsey, Margaret Zoing, Emma Devenney, Woojin S. Kim, John R. Hodges, Olivier Piguet, Glenda M. Halliday & Matthew C. Kiernan. (2019) Eating peptides: biomarkers of neurodegeneration in amyotrophic lateral sclerosis and frontotemporal dementia. Annals of Clinical and Translational Neurology 6:3, pages 486-495.
Crossref
Crossref
Vincent Grollemund, Pierre-François Pradat, Giorgia Querin, François Delbot, Gaétan Le Chat, Jean-François Pradat-Peyre & Peter Bede. (2019) Machine Learning in Amyotrophic Lateral Sclerosis: Achievements, Pitfalls, and Future Directions. Frontiers in Neuroscience 13.
Crossref
Crossref
Jeffrey M. Statland, Dan Moore, Yunxia Wang, Maureen Walsh, Tahseen Mozaffar, Lauren Elman, Sharon P. Nations, Hiroshi Mitsumoto, J. Americo Fernandes, David Saperstein, Ghazala Hayat, Laura Herbelin, Chafic Karam, Jonathan Katz, Heather M. Wilkins, Abdulbaki Agbas, Russell H. Swerdlow, Regina M. Santella, Mazen M. Dimachkie & Richard J. Barohn. (2019) Rasagiline for amyotrophic lateral sclerosis: A randomized, controlled trial. Muscle & Nerve 59:2, pages 201-207.
Crossref
Crossref
Alex G. Karanevich, Jeffrey M. Statland, Byron J. Gajewski & Jianghua He. (2018) Using an onset-anchored Bayesian hierarchical model to improve predictions for amyotrophic lateral sclerosis disease progression. BMC Medical Research Methodology 18:1.
Crossref
Crossref
Nimish J. Thakore, Brittany R. Lapin & Erik P. Pioro. (2018) Trajectories of impairment in amyotrophic lateral sclerosis: Insights from the Pooled Resource Open-Access ALS Clinical Trials cohort. Muscle & Nerve 57:6, pages 937-945.
Crossref
Crossref
Roberto Gomeni, Françoise Bressolle‐Gomeni & Maurizio Fava. (2018)
Is It Time for Going Beyond the
P
‐Value Paradigm With the Estimation of the Probability of Clinical Benefit as a Criterion for Assessing the Outcomes of a Clinical Trial? A Case Study in Patients With Major Depressive Disorder
. The Journal of Clinical Pharmacology 58:6, pages 740-749.
Crossref
Crossref
Héctor R. Martínez, César E. Escamilla-Ocañas, Carlos R. Camara-Lemarroy, María T. González-Garza, Juan M. Tenorio-Pedraza & Martín Hernández-Torre. (2017) CSF concentrations of adipsin and adiponectin in patients with amyotrophic lateral sclerosis. Acta Neurologica Belgica 117:4, pages 879-883.
Crossref
Crossref
Mei-Lyn Ong, Pei Fang Tan & Joanna D. Holbrook. (2017) Predicting functional decline and survival in amyotrophic lateral sclerosis. PLOS ONE 12:4, pages e0174925.
Crossref
Crossref
Jonathan Gordon & Boaz Lerner. (2016) Exposing and modeling underlying mechanisms in ALS with machine learning. Exposing and modeling underlying mechanisms in ALS with machine learning.
Albert A. Taylor, Christina Fournier, Meraida Polak, Liuxia Wang, Neta Zach, Mike Keymer, Jonathan D. Glass & David L. Ennist. (2016) Predicting disease progression in amyotrophic lateral sclerosis. Annals of Clinical and Translational Neurology 3:11, pages 866-875.
Crossref
Crossref
Sarah F. Cook & Robert R. Bies. (2016) Disease Progression Modeling: Key Concepts and Recent Developments. Current Pharmacology Reports 2:5, pages 221-230.
Crossref
Crossref
Stefanie Schreiber, Verena Dannhardt-Stieger, Dorothea Henkel, Grazyna Debska-Vielhaber, Judith Machts, Susanne Abdulla, Siegfried Kropf, Katja Kollewe, Susanne Petri, Hans-Jochen Heinze, Reinhard Dengler, Peter J. Nestor & Stefan Vielhaber. (2016) Quantifying disease progression in amyotrophic lateral sclerosis using peripheral nerve sonography. Muscle & Nerve 54:3, pages 391-397.
Crossref
Crossref
Hazuki Watanabe, Naoki Atsuta, Akihiro Hirakawa, Ryoichi Nakamura, Masahiro Nakatochi, Shinsuke Ishigaki, Aritoshi Iida, Shiro Ikegawa, Michiaki Kubo, Daichi Yokoi, Hirohisa Watanabe, Mizuki Ito, Masahisa Katsuno, Yuishin Izumi, Mitsuya Morita, Kazuaki Kanai, Akira Taniguchi, Ikuko Aiba, Koji Abe, Koichi Mizoguchi, Masaya Oda, Osamu Kano, Koichi Okamoto, Satoshi Kuwabara, Kazuko Hasegawa, Takashi Imai, Akihiro Kawata, Masashi Aoki, Shoji Tsuji, Kenji Nakashima, Ryuji Kaji & Gen Sobue. (2016)
A rapid functional decline type of amyotrophic lateral sclerosis is linked to low expression of
TTN
. Journal of Neurology, Neurosurgery & Psychiatry 87:8, pages 851-858.
Crossref
Crossref
Jessica Mandrioli, Sara Biguzzi, Carlo Guidi, Elisabetta Sette, Emilio Terlizzi, Alessandro Ravasio, Mario Casmiro, Fabrizio Salvi, Rocco Liguori, Romana Rizzi, Vladimiro Pietrini, Annamaria Borghi, Rita Rinaldi, Nicola Fini, Elisabetta Chierici, Mario Santangelo, Enrico Granieri, Vittoria Mussuto, Silvia De Pasqua, Eleni Georgoulopoulou, Antonio Fasano, Salvatore Ferro & Roberto D’Alessandro. (2015) Heterogeneity in ALSFRS-R decline and survival: a population-based study in Italy. Neurological Sciences 36:12, pages 2243-2252.
Crossref
Crossref
Christina Schuster, Marwa Elamin, Orla Hardiman & Peter Bede. (2015) Presymptomatic and longitudinal neuroimaging in neurodegeneration—from snapshots to motion picture: a systematic review. Journal of Neurology, Neurosurgery & Psychiatry 86:10, pages 1089-1096.
Crossref
Crossref
Huub Creemers, Hepke Grupstra, Frans Nollet, Leonard H. van den Berg & Anita Beelen. (2014) Prognostic factors for the course of functional status of patients with ALS: a systematic review. Journal of Neurology 262:6, pages 1407-1423.
Crossref
Crossref
Neta Zach, David L. Ennist, Albert A. Taylor, Hagit Alon, Alexander Sherman, Robert Kueffner, Jason Walker, Ervin Sinani, Igor Katsovskiy, Merit Cudkowicz & Melanie L. Leitner. (2015) Being PRO-ACTive: What can a Clinical Trial Database Reveal About ALS?. Neurotherapeutics 12:2, pages 417-423.
Crossref
Crossref
Robert Küffner, Neta Zach, Raquel Norel, Johann Hawe, David Schoenfeld, Liuxia Wang, Guang Li, Lilly Fang, Lester Mackey, Orla Hardiman, Merit Cudkowicz, Alexander Sherman, Gokhan Ertaylan, Moritz Grosse-Wentrup, Torsten Hothorn, Jules van Ligtenberg, Jakob H Macke, Timm Meyer, Bernhard Schölkopf, Linh Tran, Rubio Vaughan, Gustavo Stolovitzky & Melanie L Leitner. (2014) Crowdsourced analysis of clinical trial data to predict amyotrophic lateral sclerosis progression. Nature Biotechnology 33:1, pages 51-57.
Crossref
Crossref
Nazem AtassiJames BerryAmy ShuiNeta ZachAlexander ShermanErvin SinaniJason WalkerIgor KatsovskiyDavid SchoenfeldMerit CudkowiczMelanie Leitner. (2014) The PRO-ACT database. Neurology 83:19, pages 1719-1725.
Crossref
Crossref
Sabrina Paganoni, Merit Cudkowicz & James D Berry. (2014) Outcome measures in amyotrophic lateral sclerosis clinical trials. Clinical Investigation 4:7, pages 605-618.
Crossref
Crossref
Afaf Shaabi. (2022) Modelling Amyotrophic Lateral Sclerosis Progression: Logic in the Logit. SSRN Electronic Journal.
Crossref
Crossref